CAPR

Capricor Therapeutics, Inc. Common Stock

$1.59 -$0.09 -5.66%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$1.59
Total Return-$0.97
Range Today$1.57 - $1.67
52 Week Range$0.63 - $4.25
Open$1.67
Market Cap$42.17M
Volume/Average261.18K/981.43K
P/E Ratio-
Dividend/Yield-




Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-14-17 15:44 11-15-17 18:53 $2.71 $2.38 -$0.33 -12.14% jackedback
10-02-17 15:36 10-04-17 15:45 $3.85 $3.25 -$0.60 -15.58% funkmasterflexion genovahero
11-01-17 18:11 11-07-17 21:50 $2.39 $2.05 -$0.34 -14.23% jackedback
10-03-17 16:51 10-04-17 17:36 $3.12 $3.31 +$0.19 +6.09% genovahero
11-02-17 18:42 11-08-17 21:49 $2.24 $2.35 +$0.11 +4.96% vipertail67 jackedback